Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update

…, S Sadhasivam, CA Prows… - Clinical …, 2014 - Wiley Online Library
Codeine is bioactivated to morphine, a strong opioid agonist, by the hepatic cytochrome P450
2D6 (CYP2D6); hence, the efficacy and safety of codeine are governed by CYP2D6 activity…

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy

…, LH Cavallari, DJ Müller, CA Prows… - Clinical …, 2021 - Wiley Online Library
Opioids are mainly used to treat both acute and chronic pain. Several opioids are metabolized
to some extent by CYP2D6 (codeine, tramadol, hydrocodone, oxycodone, and methadone…

[HTML][HTML] Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron

…, RJ Gordon, K Hikino, CA Prows… - Clinical …, 2017 - ncbi.nlm.nih.gov
5-hydroxytryptamine type 3 (5-HT 3) receptor antagonists are used in the prevention of
chemotherapy-induced, radiation-induced and postoperative nausea and vomiting. CYP2D6 …

[PDF][PDF] Return of genomic results to research participants: the floor, the ceiling, and the choices in between

…, IJ Kullo, LS Lehmann, C McCarty, CA Prows… - The American Journal of …, 2014 - cell.com
c. Participation in research studies should be noncoercive and respectful of participant … c.
Research studies intended to examine practices for the return of genomic information should …

Design and anticipated outcomes of the eMERGE‐PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems

…, CL Perry, JF Peterson, CA Prows… - Clinical …, 2014 - Wiley Online Library
We describe here the design and initial implementation of the eMERGE‐PGx project.
eMERGE‐PGx, a partnership of the Electronic Medical Records and Genomics Network and the …

Mutations in SLC25A46, encoding a UGO1-like protein, cause an optic atrophy spectrum disorder

…, X Wang, LA Krueger, Y Peng, CE Prada, CA Prows… - Nature …, 2015 - nature.com
… (c) Image of the optic disc from patient UK II-2 showing primary temporal optic nerve pallor
… found no ragged red fibers or cytochrome c oxidase (COX)-negative fibers (data not shown). …

Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network

…, CL Perry, JF Peterson, CA Prows… - Clinical …, 2016 - Wiley Online Library
Genetic variation can affect drug response in multiple ways, although it remains unclear how
rare genetic variants affect drug response. The electronic Medical Records and Genomics (…

Nurses transforming health care using genetics and genomics

…, A Cashion, S Feetham, J Jenkins, CA Prows… - Nursing outlook, 2010 - Elsevier
Prows MSN, CNS, FAAN , Janet K. Williams PhD, RN, PNP, FAAN , Shu-Fen Wung PhD,
RN, ACNP, FAHA, FAAN … LAMIN A/C; LMNA, 2008. Available at: http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=150330 …

[HTML][HTML] Returning integrated genomic risk and clinical recommendations: The eMERGE study

…, C Ta, C Hammack, C Nelson, C Gascoigne, C Dorn… - Genetics in …, 2023 - Elsevier
Purpose Assessing the risk of common, complex diseases requires consideration of clinical
risk factors as well as monogenic and polygenic risks, which in turn may be reflected in …

Race and unequal burden of perioperative pain and opioid related adverse effects in children

…, P Ngamprasertwong, HR Esslinger, C Prows… - …, 2012 - publications.aap.org
BACKGROUND: Interindividual variability in pain perception and analgesic response is a
major problem in perioperative practice. Adult studies suggest pain management is influenced …